Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis
Year of publication: |
2006
|
---|---|
Authors: | Spalding, James R. ; Hay, Joel |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 24.2006, 12, p. 1221-1232
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Adalimumab | Cost-utility | Etanercept | Infliximab | Methotrexate | Rheumatoid-arthritis |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Nguyen, Christine M., (2012)
-
(2012)
-
Bounthavong, Mark, (2012)
- More ...
-
Special issue: Honoring William S. Comanor and 50 years of pharmaceutical economics
Hay, Joel W., (2015)
-
A special commemorative issue Honoring William S. Comanor and 50 years of pharmaceutical economics
Hay, Joel W., (2015)
-
Physician-induced demand : an empirical analysis of the consumer information gap
Hay, Joel, (1982)
- More ...